Brief: Aegirbio: COVID-Test Approved In Germany By BfArM
May 25 (Reuters) - Aegirbio AB AEGIR.ST :
* COVID-TEST APPROVED IN GERMANY BY BFARM
Source text for Eikon: ID:nWkr2DWgXS
Further company coverage: AEGIR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Subgen AI AB
See all newsBrief: Spanish Government Authorizes €19.2 Mln Investment In Subgen AI Unit
Brief: Subgen AI To Appeal Court Verdict Upholding SEK 12 Mln Regulatory Fine
Brief: Subgen AI Announces Outcome Of Directed Issue Of Shares
Brief: Subgen AI Plans Share Issue, Eyes 58.8% Substrate AI Stake
Brief: Subgen AI Says Administrative Court Upholds Fine On Magnasense